Sunshine Guojian Pharmaceutical–SEVERAL: investment, 202007 IPO $240m with 61.6m shares at $4/share

	Period	2020-07-22
	Money taker	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (SSE: 688336)
	Group	3SBio (Group)
	Money source	SEVERAL
	Product	BIOTECH
	Product 2	investment banking

Record changed: 2020-08-26

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for 3SBio (Group)

[1] Numab Therapeutics AG. (3/9/20). "Press Release: Numab Therapeutics Closes Series B Financing at CHF 22M to Advance Portfolio of Novel Multi-specific Antibodies in Immuno-Oncology". Wädenswil (Zurich)....
[2] Numab Therapeutics AG. (12/12/19). "Press Release: Numab Therapeutics and 3SBio’s Subsidiary Sunshine Guojian Form Partnership to Develop a Portfolio of Novel Multi-specific Antibodies in Immuno-Oncology". Wädenswil, Shengyang & Shanghai....
[3] Verseau Therapeutics, Inc.. (2/11/19). "Press Release: 3SBio and Verseau Establish Global Clinical Development Collaboration for First-in-class Immuno-Oncology Therapies". Shenyang & Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]